The Feds just started charging drug company executives for price fixing

The Department of Justice has accused two drug industry executives of fixing prices of generic drugs.

Bloomberg is reporting that the former president and former CEO of Heritage Pharmaceuticals were both charged Monday.

In November, Bloomberg reported that Federal prosecutors may start bringing down charges regarding price fixing as part of a larger investigation into generic drugmakers. EpiPen-maker Mylan and Teva Pharmaceuticals are among the other companies under investigation.

This story is developing.

NOW WATCH: Here’s what happens to your body when you stop eating sugar

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at